Dr Matthew Flook
MBBS (UK) BSc(Hons)
MRCP(UK) PG Diploma (Cancer Sciences)
MRCP (Medical Oncology) (UK)
Dr Matthew Flook completed his undergraduate training at Imperial college London. He went on to complete his core medical training in London at the Royal Brompton & Royal Marsden Hospitals as well as at Imperial Healthcare nhs trust.
Dr Flook completed his Medical Oncology training in London at Chelsea & Westminster, Hammersmith and Charing Cross Teaching Hospitals. He completed a Diploma in Cancer Sciences at the Institute of Cancer Research in London.
Dr Flook taught at Imperial college London, Warwick University, at NTU and LKC here in Singapore. He developed a teaching programme for junior doctors at University Hospitals Coventry and Warwick in Haematology and Oncology. Dr Flook worked as a clinical educator at LKC medical school.
Dr Flook has subspecialty research interest in Breast, Lung and Colorectal cancer as well as treatment in the neoadjuvant setting, molecular and genomic predictive biomarker driven treatment & immunotherapy. Dr Flook has publications in a number of peer reviewed journals and has been an investigator in a large number of clinical trials of all phases.
Dr Flook has participated as a faculty member and expert panellist at large international conferences such as the Asia Pacific Breast cancer conference 2018, 2019 and presented at international cancer conferences in Singapore, London and Kuala Lumpur.
Dr Flook is an expert in genetic predisposition (such as BRCA mutation and Lynch syndrome) and helped to set up and run the genetic predisposition service at Tan Tock Seng from 2017.